 Connection
Rajeev Vibhakar to Neoplastic Stem Cells
This is a "connection" page, showing publications Rajeev Vibhakar has written about Neoplastic Stem Cells.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.008 |
|
|
|
-
Venkataraman S, Alimova I, Balakrishnan I, Harris P, Birks DK, Griesinger A, Amani V, Cristiano B, Remke M, Taylor MD, Handler M, Foreman NK, Vibhakar R. Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15; 5(9):2355-71.
Score: 0.315
-
Alimova I, Venkataraman S, Harris P, Marquez VE, Northcott PA, Dubuc A, Taylor MD, Foreman NK, Vibhakar R. Targeting the enhancer of zeste homologue 2 in medulloblastoma. Int J Cancer. 2012 Oct 15; 131(8):1800-9.
Score: 0.279
-
Blanco-Carmona E, Paassen I, He J, DeMartino J, Büllesbach A, Anderson N, Buhl JL, Federico A, Mauermann M, Brok M, Straathof K, Behjati S, Vibhakar R, Donson AM, Foreman NK, Shaw M, Frühwald MC, Korshunov A, Hasselblatt M, Thomas C, Franke N, Kranendonk MEG, Hoving EW, Jäger N, Johann PD, Pfister SM, Filbin MG, Kool M, Drost J. A cycling, progenitor-like cell population at the base of atypical teratoid rhabdoid tumor subtype differentiation trajectories. Neuro Oncol. 2025 Dec 01; 27(12):3260-3275.
Score: 0.176
-
DeSisto J, Balakrishnan I, Knox AJ, Link G, Venkataraman S, Vibhakar R, Green AL. PRMT5 Maintains Tumor Stem Cells to Promote Pediatric High-Grade Glioma Tumorigenesis. Mol Cancer Res. 2025 Feb 06; 23(2):107-118.
Score: 0.166
-
Savage N, Danis E, Chokshi CR, Custers S, Shaikh MV, Miletic P, Venugopal C, Brown KR, Vibhakar R, Moffat J, Singh SK. CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastoma. Sci Rep. 2025 Oct 16; 15(1):36228.
Score: 0.044
-
Ocasio JK, Babcock B, Malawsky D, Weir SJ, Loo L, Simon JM, Zylka MJ, Hwang D, Dismuke T, Sokolsky M, Rosen EP, Vibhakar R, Zhang J, Saulnier O, Vladoiu M, El-Hamamy I, Stein LD, Taylor MD, Smith KS, Northcott PA, Colaneri A, Wilhelmsen K, Gershon TR. scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy. Nat Commun. 2019 12 20; 10(1):5829.
Score: 0.029
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|